Evidence map›Paper›PMID 38059628›Full record

ArticleMicrobiology spectrum2024

Development of a quadruple qRT-PCR assay for simultaneous identification of hypervirulent and carbapenem-resistant

Zhixiang Xu, Baisheng Li, Yushan Jiang, Jia Huang, Lebin Su, Weibo Wu, Qilin Pang, Zhuolin Li, Jiaqi Zhang, Xiaohe Li and 9 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Multiplex PCR assay for the rapid detection ofJournal of medical microbiology · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. HypervirulentPathogens & immunity · 2024
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Zhixiang Xu *Savid Medical School, University of Chinese Academy of Sciences , Beijing, China.
Baisheng Li *Guangdong Provincial Key Laboratory of Pathogen Detection for Emerging Infectious Disease Response, Guangdong Center for Disease Control and Prevention , Guangzhou, Guangdong, China.ORCID 0000-0003-1842-316X
Yushan Jiang *BSL-3 Laboratory (Guangdong), Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University , Guangzhou, Guangdong, China.
Jia Huang *Shenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Clinical Research Center for infectious disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology , Shenzhen, Guangdong, China.
Lebin Su *Zhaoqing Center for Disease Control and Prevention , Zhaoqing, Guangdong, China.
Weibo WuShenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Clinical Research Center for infectious disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology , Shenzhen, Guangdong, China.
Qilin PangShenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Clinical Research Center for infectious disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology , Shenzhen, Guangdong, China.
Zhuolin LiBSL-3 Laboratory (Guangdong), Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University , Guangzhou, Guangdong, China.
Jiaqi ZhangShenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Clinical Research Center for infectious disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology , Shenzhen, Guangdong, China.
Xiaohe LiShenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Clinical Research Center for infectious disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology , Shenzhen, Guangdong, China.
Jun WangShenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Clinical Research Center for infectious disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology , Shenzhen, Guangdong, China.
Fulan CenShenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Clinical Research Center for infectious disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology , Shenzhen, Guangdong, China.
Ling PengShenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Clinical Research Center for infectious disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology , Shenzhen, Guangdong, China.
Jinhu LiangShenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Clinical Research Center for infectious disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology , Shenzhen, Guangdong, China.
Fuxiang WangShenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Clinical Research Center for infectious disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology , Shenzhen, Guangdong, China.
Chang LiuZhaoqing Center for Disease Control and Prevention , Zhaoqing, Guangdong, China.ORCID 0009-0008-0070-0871
Chenguang ShenBSL-3 Laboratory (Guangdong), Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University , Guangzhou, Guangdong, China.ORCID 0000-0001-8607-3750
Yingxia LiuSavid Medical School, University of Chinese Academy of Sciences , Beijing, China.ORCID 0000-0001-6335-3346
Yang YangShenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Clinical Research Center for infectious disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology , Shenzhen, Guangdong, China.ORCID 0000-0002-6489-4459

Funding

Shenzhen Municipal Science and Technology Innovation Council | Shenzhen Science and Technology Innovation Program JSGG20201103153802007
6 · The paper itself

Abstract

importanceGlobally, the increasing number of hypervirulent

Indexed as

Carbapenem-Resistant EnterobacteriaceaeKlebsiella InfectionsAnti-Bacterial AgentsCarbapenemsHumansKlebsiella pneumoniaeReal-Time Polymerase Chain ReactionVirulenceAnti-Bacterial AgentsCarbapenemscarbapenem-resistantdifferential diagnosishypervirulentKlebsiella pneumoniaemultiplex qRT-PCR

Identifiers

PMID38059628
PMCPMC10783029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.